retatrutide clinical trials weight loss Retatrutide: What It Is & How This New Drug Works How Does Retatrutide Work? Doctor

On December 22, 2025, the FDA approved Novo Nordisk's once-daily oral semaglutide (Wegovy pill, 25 mg) for chronic weight management and cardiovascular risk reduction (FDA / Novo Nordisk, 2025)

Meet Jessica Potere Health MD is more than just a prescription We provide the right medication and tailored support so you can lose weight safely, conveniently, and effectively

If you need assistance, contact us today

While adult obesity rates have driven commercial focus, childhood obesity has reached epidemic proportions globally, with limited therapeutic options available for younger patients

Notably, a 24-week semaglutide trial reported improvements in sperm morphology and cholesterol levels while maintaining stable hormone levels

People who train consistently, eat enough protein, and manage their deficit intelligently throughout their time on the drug retain the majority of their lean mass and face none of the downstream consequences associated with significant muscle loss